…excited that it’s been submitted to FDA but here’s what concerns me…
- My daughter’s infusion sites fail with some frequency in the night, meaning she’ll go high and start developing ketones…how will Control-IQ deal with that? The answer is not to just keep correcting!
- Because of #1, her endo has told her to use a pen for boluses to reduce insulin going through her infusion site - does the X:2 have a means of inputting insulin given not using the pump?
- My daughter is currently using the Dexcom G4 and it’s reliability is pretty spotty. Is the G6 really that much better?
- Related to #3 - the G4’s accuracy drops when she doesn’t keep herself sufficiently hydrated, or sometimes stops reading altogether if she sleeps on it weird - hard to imagine these won’t still be issues with the G6. (A Dexcom rep also told me that the G6 was giving skinny people problems…)
Bottom line - how reliable will the data be that Control-IQ bases its decisions on?
Interested in folks’ thoughts.